Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk
A registered study to follow
This record describes a registered study with results posted in the registry. Registration, recruitment and completion are different from evidence of effectiveness.
Trial details
- Status at retrieval
- COMPLETED
- Phase
- Phase 2
- Enrollment
- 51 (actual)
- Registry results
- Posted — read the source
- Last registry update
- 20 Nov 2025
- Conditions
- Non-Alcoholic Fatty Liver Disease; Obesity; Obesity, Abdominal; Liver Fat; Fatty Liver
Questions for the community
- Which parts of the study design matter most when interpreting this source?
- What would you need to know before applying the findings to a different population?
The community requires an account and moderator review. Nothing is posted automatically.
Study-design labels are drawn from source metadata or provisional title signals and require verification against the methods. These records are educational references, not treatment recommendations.